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The purpose of this paper is to provide the biomedical imaging community with details of a new high resolution contrast imaging
approach referred to as “acoustic angiography.” Through the use of dual-frequency ultrasound transducer technology, images
acquired with this approach possess both high resolution and a high contrast-to-tissue ratio, which enables the visualization
of microvascular architecture without significant contribution from background tissues. Additionally, volumetric vessel-tissue
integration can be visualized by using b-mode overlays acquired with the same probe. We present a brief technical overview of
how the images are acquired, followed by several examples of images of both healthy and diseased tissue volumes. 3D images
from alternate modalities often used in preclinical imaging, contrast-enhanced micro-CT and photoacoustics, are also included to
provideaperspectiveonhowacousticangiographyhasqualitativelysimilarcapabilitiestotheseothertechniques.Thesepreliminary
images provide visually compelling evidence to suggest that acoustic angiography may serve as a powerful new tool in preclinical
and future clinical imaging.
1. Introduction
Bloodvesselstructureandpatencyareknowntoberelatedto
the state and progression of many diseases [1, 2]. Abnormal
vessel and vessel network morphologies have been positively
correlated to malignancy across species [3, 4]. In preclinical
studies of the disease and drug research, there are several
noninvasive imaging modalities that can be utilized to visu-
alize blood vessel structure. These are magnetic resonance
imaging (MRI), computed tomography (CT), ultrasound,
and more recently—photoacoustic imaging. To select one
of these imaging methods, researchers must compromise
between the variables of system including study cost, data
acquisition time, ionizing radiation dose, imaging depth,
and image resolution. High-field MRI is the most expensive,
requires the longest acquisition times, and requires a dedi-
cated facility for shielding and maintenance. CT is also fairly
expensive, bulky, and primarily limited by a high ionizing
radiation dose. Ultrasound is the least expensive, the most
portable, and provides the fastest image acquisition. Pho-
toacoustic imaging has similar portability to ultrasound and
can provide high resolution images of the microvasculature
as well as additional functional information (such as blood
oxygen saturation), but is the most limited in penetration
depth among these modalities.
In the past, the reputation of ultrasound has been as
a modality with limited ability to assess microvasculature
structure. However, recent advances in high frequency ultra-
sound technology have substantially improved image quality
to the point that it has become a favored technique for many
researchers studying small animal models. While conven-
tionalhighfrequencyultrasounddoesstilllacktheresolution
andcontrastofrecentlypublishedCT[5]andMRstudies[6],
it has been effectively implemented to monitor disease pro-
gression and therapeutic responses in many different cancer
models, including pancreatic [7], prostate [8], melanoma [9],
ovarian [10], lung [11], and mammary [12] cancer models.2 International Journal of Biomedical Imaging
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Figure1:Photographofthedual-frequencyprobe,illustratingthesideview(a)andthebottomview(b)showingthetwotransducerelements.
The probe housing is a modified VisualSonics “RMV” transducer housing.
Traditional noncontrast-enhanced ultrasound excels at
imaginganatomicalfeatures,butischallengedwhen imaging
blood flow in small vessels due to weak ultrasound scatter
from blood components. Thus, for imaging blood flow in
small vessels with high sensitivity, clinical ultrasound relies
on the application of intravascular microbubble contrast
agents (MCAs). Because of the nonlinear behavior of MCAs
in response to an ultrasound pulse, their acoustic scatter can
bedetectedandseparatedfromtissueenablingimageandsig-
n a lp r o c e s s i n gt e c h n i q u e st os e g m e n tb l o o dv e s s e l sf r o mt h e
tissue background. Most nonlinear imaging techniques are
most efficient near the resonant frequencies of microbubble
contrast agents, typically less than 10MHz, which is a good
matchforclinicalultrasoundimagingapplications.However,
for the improved imaging resolution required in small-
animalimaging,highfrequencyultrasoundsystemstypically
utilize frequencies in the 20–60MHz range, substantially
above the resonant frequencies for most microbubbles. Typ-
ically, high frequency imaging systems have been challenged
to perform nonlinear contrast imaging for this reason.
Here, we report the technique of high resolution
microvascular imaging using a prototype dual-frequency
transducer which enables vascular imaging with both high
contrast sensitivity and imaging resolution. With this tech-
nology, the above-mentioned resolution versus contrast-
sensitivitytradeoffcanbepartiallycircumventedbydetecting
the high frequency components from the wideband acous-
tic energy produced by MCAs when they are excited at
low frequencies near their resonance. The potential of this
technique was initially demonstrated by Kruse and Ferrara
[13], where it was observed that microbubbles excited with
short pulses at 2.25MHz produced broadband energy that
exceeded 45MHz. The main challenge of this approach to
date, however, has been the lack of available transducers that
could transmit energy at low frequencies (such as 2–4MHz)
toexcitemicrobubblesand,atthesametimeconfocallydetect
s c a t t e r e de c h o e si nt h e1 5 – 4 5M H zb a n d w i d t h .
Our prototype transducer consists of both low and high
frequency confocal elements, in contrast to standard ultra-
sound imaging transducers which typically operate within a
single frequency range. The low frequency element (4MHz)
excites MCAs near their resonance, and the high frequency
element (30MHz) receives high frequency content from
t h ee x c i t e dm i c r o b u b b l e s .Th eb r o a d l ys e p a r a t e df r e q u e n c y
bandwidths of the two elements used in our system are what
differentiate this approach from the dual-frequency probes
previously presented by other groups [14–16]a n da r ew h a t
enable its high resolution and high contrast imaging ability.
This approach enables detection of signal from microbubble
contrast with almost complete tissue suppression. Further-
more, because of the high frequency receive, the system is
able to achieve high resolution, yet with less attenuation
than systems operating with high frequency on both trans-
mit and receive. The resulting ultrasound images illustrate
high resolution depictions of the microvasculature, with-
out background from surrounding tissue, not unlike X-ray
angiography images. Furthermore, through use of traditional
s i n g l e - f r e q u e n c yp u l s e - e c h o ,t i s s u eb - m o d ei m a g e sc a nb e
acquired for anatomical reference. Thus, we refer to images
acquired with this technology as “acoustic angiography”. In
this paper we discuss the prototype transducer and present
exampleofhighresolutioninvivo3Dimages,discussinghow
t h e s ei m a g e sc o u l db eu s e df o rd i a g n o s t i c s .F o rq u a l i t a t i v e
comparison, we also provide contrast-enhanced CT and
photoacoustic images to illustrate that acoustic angiography
could be considered as an alternative to these other tech-
niques.
2. Materials and Methods
2.1. Prototype Imaging System. The custom dual-frequency
transducer was fabricated by integrating a high frequency
broadband 30MHz transducer element (RMV 707, Visual-
Sonics, Toronto, ON, Canada) with a concentric low fre-
quency 4MHz annulus (Figure 1), as previously described
[17]. The radius of curvature for the 4MHz element was
12.7mm,whichmatchedthatofthe30MHzreceiverelement
for overlapping depth of field. The selection of the 30MHz
element was made to ensure that both rats and mice could be
imagedwithgoodspatialresolution,whilethe4MHzpulsing
frequency was selected because it is near the resonance fre-
quency of many of the contrast agents utilized by our lab. It is
likely that other frequency ranges would be optimal for otherInternational Journal of Biomedical Imaging 3
contrast agents, or applications that require different depths
of penetration.The electrical return path from both elements
w a si s o l a t e ds ot h a tt h et r a n s m i t t e rc o u l db ed r i v e nb ya n
external pulser. To drive the system, we utilized a commonly
implemented high frequency preclinical Vevo770 ultrasound
scanner (VisualSonics, Toronto, ON, Canada) that had been
modifiedtoworkwithourcustomdual-frequencyprobe.The
Vevo770 was altered by insertion of a 10MHz high-pass filter
(TTE, Los Angeles, CA, USA) after the receiver amplifier but
beforeanalogtodigitalconversion.Thisservedtoensurethat
n ot i s s u es i g n a ll e a k e di n t ot h ed a t ad u r i n gd u a l - f r e q u e n c y
imaging. The trigger was synchronized to an external arbi-
trary waveform generator (AWG 2021, Tektronix, Beaverton,
OR, USA) to drive the low frequency element. Signals from
the waveform generator were amplified by 55dB through a
RF amplifier (ENI, Rochester, NY, USA) before exciting the
transmitter.
2.2. Characterization of the Probe. Beam-field mapping
with a needle hydrophone enabled determination of the
−6dB beamwidths of the transmit and receive transducer
(Figure 2). The −6dB lateral beamwidth for the 4MHz
element was 298𝜇m, and the −6dB lateral beamwidth for
the 30MHz element was 137𝜇m. During this procedure,
it was observed that the two elements were not exactly
confocal, and the lateral focal zones were actually misaligned
by 90𝜇m. Thus, the −6dB focal spot of the 30MHz element
was centered along the edge of the −6dBfocalspotofthe
4MHztransducer(Figure 2(c)). This misalignment was due
to the challenge of the manufacturing process and will be
an area for improvement in future prototypes. The axial
−6dB beamwidths of the two transducers were 7.05mm and
1.99mm, for 4MHz and 30MHz, respectively. The focal spot
misalignment in the axial direction was only 0.9mm. It
i sa n t i c i p a t e dt h a tw i t hc o r r e c t i o nt ot h e s em i s a l i g n m e n t s ,
future probes will be able to provide similar or improved
sensitivity at reduced excitation energies.
Transmission with the high frequency (30MHz) element
allowed traditional high frequency b-mode imaging in order
to obtain anatomical images, whereas transmission with the
low frequency (4MHz) element enabled Acoustic Angiogra-
phy to obtain contrast only images.
Both the 4MHz and 30MHz transducers had approxi-
mately 100% bandwidth. A frequency domain representation
approximating the probe’s two transducer bandwidths, the
filter cutoff, and example tissue and microbubble responses
c a nb ef o u n di nFigure 3.
Images were acquired and saved on the ultrasound
system, then later exported for offline analysis. All images
were acquired in 3D image using a linear translational motor
s t a g es y n c h r o n i z e dw i t ht h ef r a m et r i g g e r .
2.3. Animal Imaging. All animal studies were performed in
rats with a protocol approved by the University of North
Carolina at Chapel Hill Institutional Animal Care and Use
Committee. Seven animals were imaged for this study: three
animals with a flank tumor model, three healthy controls
imaged in the same region, and one animal imaged for
a healthy kidney for comparison to contrast-enhanced CT
imaging. The tumor model (syngeneic fibrosarcoma: “FSA”;
[18]) was initiated by propagating tumor tissue through
subcutaneous implant in the rodent flank. Initial tumor
samples were graciously provided by the Dewhirst Lab at
Duke University. The acoustic angiography strategy neces-
s i t a t e st h eu s eo fc o n t r a s ta g e n t st op r o v i d es i g n a lf r o mt h e
vasculature.Inthesestudies,microbubblecontrastagentwith
a polydisperse diameter distribution centered at 0.9𝜇mw i t h
a standard deviation of 0.45𝜇m was prepared as previously
described [19]. Microbubble contrast was diluted in saline
a n da d m i n i s t e r edv i aata ilv e i nc a th e t e rw i thas y ri n g ep u m p
at 70𝜇L/min at a concentration of 3.3⋅10
9 bubbles/mL. The
administrationofcontrastbegan20secondspriortoimaging;
this waiting period would be sufficient to for the initial bolus
of contrast to perfuse the tissue prior to image acquisition.
Imaging pulses were 4MHz single cycle sinusoids with a
peak negative pressure of 1.23MPa (mechanical index =
0.62). 3D ultrasound images were acquired with interplane
step sizes of 150–200𝜇ma n dr e q u i r e df e w e rt h a n3m i n u t e s
to acquire. Since the tissues of interest were in the lower
abdomenandflank,respiratorymotionartifactswerelimited.
Acquisition of all ultrasound images was coplanar with the
axial anatomical plane while the animals were in dorsal
recumbency.
TheCTimageswereacquiredoftheratkidney45minutes
after the injection of contrast. The contrast agent imple-
mented was Fenestra VC (Advanced Research Technologies,
Montreal, QC, Canada), an iodinated lipid blood pool CT
contrast agent injected at a concentration of 3mL/450g
tissue. CT images were acquired using the GE eXplore
SpeCZT CT 120SPECT/CT (GE Healthcare, London, ON,
Canada) at 90kVp using 900 views over 360 degrees with
total output 576mAs. The total dose delivered was 300mGy.
Reconstructionwasperformedon100𝜇misotropicgridwith
a standard Feldkamp-Davis-Kress algorithm.
The photoacoustic images were reproduced with permis-
sion from work by Zhang et al. [20]. That study implemented
a photoacoustics system using an excitation wavelength of
590nm, a 38𝜇m thick polymer ultrasound transducer with
a −3dB acoustic bandwidth of 22MHz, and a frequency
response characterized by a smooth roll-off with its zero
response occurring at 58MHz [20].
3. Results
Imagingstudieswithourdual-frequencytransducerimmedi-
ately demonstrated a new paradigm in ultrasound imaging.
Images illustrated signal from contrast only, with virtually
no tissue signal (Figure 4). The result was images of tissue
microvascular structure; hence, we refer to this technique as
“acoustic angiography.”
One likely application of acoustic angiography is visu-
alization of tumor microvascular structure with anatomical
reference. Figure 5(a) illustrates the ability of the probe to
a c q u i r eb o t hv a s c u l a ri m a g e sa n dt i s s u ei m a g e so ft h es a m e
in vivo sample volume. Vessels imaged in acoustic angiog-
raphy mode are overlaid with the traditional high-frequency4 International Journal of Biomedical Imaging
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Figure 2: Beam plots showing the −6dB beamwidth for the (a) 4MHz (298𝜇m) and (b) 30MHz (137𝜇m) elements. Panel (c) illustrates the
confocal alignment of the transducers, where the circles approximate the −6dB regions of the two transducers. There was a misalignment
of approximately 90𝜇m of the two transducers on this prototype probe due to the challenge of the manufacturing process. Improving the
element focal alignment is an obvious way to improve the performance of this system in future iterations.
b-mode image, thereby enabling the visualization and spatial
characterization of vessel-tissue integration.
Figure 6 depicts both b-mode and acoustic angiography
images of the microvasculature surrounding two different
tumors versus microvasculature from two normal tissue
volumes. Differences between the vascular architecture
w i t h i nt h e s et w ot y p e so ft i s s u ev o l u m e sa r eo b s e r v a b l e .
Highly tortuous vessel structure is typical of angiogenic
tumor vasculature [3, 4] and is not observed with as much
frequency in the data for the healthy flank as it is in theInternational Journal of Biomedical Imaging 5
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Figure 3: A frequency domain representation of the signals of all
transmit and receive components of acoustic angiography imaging.
The tissue and bubble responses were acquired using an exper-
imental system described previously [17] and are displayed here
to illustrate the relationship between the bandwidths and the two
transducer elements as well as the tissue and bubble responses, for
example, acoustic angiography imaging conditions.
tumor-bearing tissue volumes (Figure 6). Further analysis of
microvasculature morphology is outside of the scope of this
introductory paper, though these images provide compelling
evidenceofthepossibilityofapplyingthisimagingtechnique
toward quantitative approaches to assessing vessel architec-
ture.
3.1. Acoustic Angiography in Comparison to Photoacoustic
Imaging. Currently, photoacoustics is the gold standard
noninvasive imaging technique for visualizing superficial
microvascular structure. However, acoustic angiography has
the potential to acquire similar images of microvessel net-
works.Toqualitativelycompareacousticangiographyimages
against images acquired with a photoacoustic imaging sys-
tem, we present data of subcutaneous microvasculature in
rodents with both imaging methods. Figure 7(a) illustrates
vasculature in the lower abdomen of a rat acquired with
contrastultrasoundattransmit4MHzandat30MHzreceive.
Figure 7(b)illustratesvasculatureintheabdomenofamouse
obtained by photoacoustics as acquired by Zhang et al. [20].
In this image, the photoacoustic resolution was approxi-
mately 90𝜇m (depth) by 130𝜇m( l a t e r a l ) ,a n dt h ei m a g i n g
depth of field was 2mm. The acoustic angiography images
are of lower resolution (approximately 150𝜇m (depth) by
200𝜇m (lateral)); however, they illustrate a greater depth of
penetration in this particular data set (5mm in this case).
Note that this comparison is not intended to suggest that
one modality has superior resolution or penetration depth
than the other; however, rather, our goal is to illustrate
that acoustic angiography provides pulse-echo ultrasound
with a method to achieve maps of vascular structure on
a resolution and depth scale which were previously only
available through photoacoustics. Although not presented
here, newer photoacoustics techniques have illustrated sub-
100𝜇m spatial resolution at depths of almost 10mm [21].
Similarly, we estimate that acoustic angiography could be
achieved at depths up to several centimeters by reducing the
receiving frequency, albeit at the expense of a reduced spatial
resolution and with more background noise from tissue.
Due to our transducer’s fixed focus, we were unable to fully
characterize limits on resolution at deeper depths, although
this will be a focus of future work.
3.2. Acoustic Angiography in Comparison to Micro-CT. We
alsoqualitativelycomparedacousticangiographytocontrast-
enhanced CT, which has also been used for microvascular
imaging. Coronal maximum intensity projections (MIPs)
through the ultrasound and CT acquisitions of the same
kidney were performed (Figure 8). The CT dataset was
reconstructed with a 100𝜇mv o x e lg r i d ,w h i c hr e s u l t e d
in an improved SNR, compared to the ultrasound image’s
50𝜇m voxel grid. Despite the slightly lower resolution of
the ultrasound, previously measured to be approximately
150𝜇m[ 17], the two imaging techniques illustrate similar
anatomicalmicrovascularfeatureswithintheratkidney.This
is illustrated within the line profiles in Figure 8(c).Th e s e
profiles were intensity normalized for display purposes and
illustrate analogous spatial resolutions, albeit with slightly
highernoiseintheultrasoundsignal.Thisincreaseinnoiseis
expected, due to the 63% smaller voxel size in the ultrasound
image (50 × 50 × 150𝜇mc o m p a r e dt ot h eC T ’ s1 0 0× 100 ×
100𝜇mv o x e l s ) .
4. Discussion and Summary
The new contrast imaging technology demonstrated herein,
which we refer to as acoustic angiography, has the capability
to obtain images of microbubbles at high frequencies tra-
ditionally not utilized for nonlinear contrast imaging. The
resulting images thus illustrate high resolution (∼150𝜇m)
contrast-enhanced images of superficial microvasculature.
Due to the tissue suppression achieved by detection of only
harmonicenergywellabovetherangeproducedbytissue,the
resulting data also illustrates a high contrast-to-tissue ratio.
Our prototype transducer utilized a 4MHz transmit,
selected to take advantage of the resonant frequencies of the
contrast agents utilized in our lab and 30MHz receive for
rodent imaging. It is likely that other transmit and receive
combinations would be more optimal for other contrast
agents, or for different depths of penetration. The tradeoff
between resolution, depth of penetration, and signal sepa-
ration are limitations of the acoustic angiography imaging
approach. As with all high frequency ultrasound imaging
methods, penetration depth is limited to a few centimeters
due to the increased absorption of sound at high frequencies.
One-way attenuation may be an advantage of this technique,
as the high frequency components are only attenuated on
receive since the bubble acts as the source. However, this
is also a limitation as there is limit to how aggressively the
microbubbles can be driven. In a prior study with detection
ofhigh-frequencycontentfrommicrobubblesreceivedwitha6 International Journal of Biomedical Imaging
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Figure 4: (a) 2D and (b) 3D “b-mode” ultrasound images from the same sample volume illustrating a subcutaneous tumor in a rat. (c)
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Figure 5: (a) An overlay of the microvasculature within a tumor provided by acoustic angiography (red) onto a tissue-only image provided
by high frequency b-mode (grayscale). This figure was created using 3D slicer (National Institutes of Health) with a 3D rendering of the
acoustic angiography data simultaneously displayed with a grayscale orthoslice of the b-mode data. Displaying data in this fashion illustrates
microvessel and tissue morphologies, as well as vascular-tissue integration. Scale bar = 0.5cm. (b) A cartoon illustrates the approximate
location of this 3D image volume.
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Figure 6: Multiple comparisons of 3D tissue volumes: two containing a tumor (left) and two healthy controls (right). The bottom images are
acousticangiography maximumintensityprojections,whilethetopimages areb-modeacquisitionsofthesametissuevolumes.Thetortuous
and chaotic morphologies of the vessels in the presence of a lesion are contrasted by the relatively homogeneous vasculature in the healthy
volume (tumor boundaries delineated in acoustic angiography image with dotted line). Image volumes = ∼0.75 × 1.25 × 1.5cm (axial, lateral,
and elevational). A cartoon on the right indicates the imaging location and orientations of image volumes.International Journal of Biomedical Imaging 7
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Figure 7: Comparison of acoustic angiography (a) to a photoacoustic imaging approach (b). The orientations of the acoustic angiography
images have been purposefully arranged to mimic the photoacoustic images (adapted, with permission, from authors [20]) to allow a quick
comparison between the two modalities. The imaging location of the acoustic angiography image was similar to that presented in Figure 6.
similar30MHztransducer,itwasobservedthatmicrobubble
signal in response to 2MHz excitation increased until an
MI of approximately 0.45, after which it leveled out, likely
whenmicrobubbledestructionbegantodominate[17].Asthe
receiving frequency is reduced, penetration depth increases,
yet our ability to separate signal from tissue and contrast
is also reduced. For our prototype probe, an additional
limitation was the fixed focus of the transducer’s current
form factor, which also provided a fairly narrow depth of
field (∼1c m ) .D u a lo rm u l t i f r e q u e n c ya r r a y sw i t hd y n a m i c
focusing will alleviate this problem in the future.
We suggest that acoustic angiography could perform
similarly to micro-CT, MRI, or photoacoustic imaging in
certain scenarios. Ultrasound imaging can be low cost and
highthroughputandavoidssomeofthedrawbacksofCTand
MR, such as ionizing radiation dose (CT), and high cost, and
long acquisition times (MR). Both photoacoustic imaging
and acoustic angiography have similar tradeoffs between
resolutionanddepthofpenetration.However,photoacoustic
imaginghastheadditionaladvantagesthatitdoesnotrequire
a contrast agent, and that photoacoustic data can be used
to derive other parameters about the target tissue, such
as oxygen saturation. However, acoustic angiography may
present an advantage of cost and simplicity over photoacous-
tics, since the latter requires a high power laser for signal
generation. Furthermore, it might also be possible to com-
bine acoustic angiography with targeted microbubbles for
molecular imaging coregistered with microvascular features.
This concept will require further evaluation to determine
if acoustic angiography can be performed at low enough
energies as to not destroy adherent targeted contrast agents.
The suppression of tissue signal and microvascular imag-
ingabilitydemonstratedbytheimageswithinthispaperpro-
videmotivationforthedevelopmentofadditionaltransducer
designs to implement acoustic angiography. One obvious
application of acoustic angiography is as a high throughput
imaging technique for preclinical studies where there is a
need for microvascular analysis, since the imaging resolution
and depth are well suited to image rodents.
Preclinical arrays could be designed for larger animal
models, such as for rabbit or dog imaging. It is possible
that in each of these clinical and preclinical applications the8 International Journal of Biomedical Imaging
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Figure 8: A comparison between the CT and ultrasound images
acquired of the same kidney. The slight anatomical warping due to
ultrasound probe contact with tissue resulted in a lack of direct one-
to-one visual correspondence between the two 3D images, though
the same anatomy is contained within each image. (a) Maximum
intensity projections of image data. The spleen is visible in each of
these images to the right of kidney (indicated with an “S”). (b) En
face cuts through the 3D image. (c) Line profiles (dashed yellow
lines) across two corresponding vessels near the spleen (dashed
yellow lines) suggest similar feature sensitivity.
presence of disease-associated vascular abnormalities could
b ed e t e c t e db ya c o u s t i ca n g i o g r a p h y ,a sc o u l dt h em o d i fi c a -
tions to these vascular networks (such as the elimination or
normalization of tumor vasculature) by effective therapeutic
regimens. In the future, this technique may also find a role in
clinical imaging of superficial tissues or tumors.
Clinicalimplementationofthistechniquewilldependon
both the commercialization of appropriate hardware, as well
as the increased regulatory acceptance of ultrasound con-
trast. While microbubbles are utilized for several oncology
applications in Europe and Asia, they are still only approved
f o ru s eb yt h eU n i t e dS t a t e sF o o da n dD r u gA d m i n i s t r a -
tion for cardiac applications. Nevertheless, data suggest that
ultrasound contrast agents are very safe [22, 23], and it is
likely that contrast ultrasound techniques will continue to
gain increasing approval worldwide as they evolve to provide
new information beyond that attainable with noncontrast
techniques.
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